CIK: 0001825034
Total reported value
$392.3M
Reporting period: 2026-03-31 · Number of holdings: 10
Euclidean Capital LLC disclosed 10 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $392.3M and a quarterly turnover rate of 10.9%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "E"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add VEU
+8.5% $23.6M
Add ORIC
0.0% $4.4M
Trim INDA
0.0% -$2.7M
Trim VTV
0.0% $2.7M
Trim FHTX
0.0% -$975.7K
Add ALEC
0.0% $771.6K
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | VEU | Vanguard Ftse All-world Ex-u | ETF-Other | 62.09% | +2.56% | +8.47% | |
| 2 | VTV | Vanguard Value ETF | ETF-Other | 26.01% | -0.87% | — | |
| 3 | INDA | Ishares Msci India ETF | ETF-Other | 4.41% | -1.00% | — | |
| 4 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 3.20% | +1.01% | — | |
| 5 | FHTX | Foghorn Therapeutics INC | Stock-Other | 1.92% | -0.38% | — | |
| 6 | PMVP | Pmv Pharmaceuticals INC | Stock-Other | 0.83% | -0.06% | — | |
| 7 | ALEC | Alector INC | Stock-Other | 0.72% | +0.17% | — | |
| 8 | SRZN | Surrozen INC | Stock-Other | 0.65% | +0.11% | — | |
| 9 | TNYA | Tenaya Therapeutics INC | Stock-Other | 0.18% | -0.02% | — | |
| 10 | SRZNW | Surrozen Inc-cw25 | Stock-Other | — | — | — |
Performance for Q3 2026
+1.9%
Performance Last 4 Quarters
+22.4%
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 10 | $392.3M | 11 | |
| 2025-12-31 | 12 | $369.5M | 48 | |
| 2025-09-30 | 11 | $238.0M | 68 | |
| 2025-06-30 | 11 | $305.7M | 0 | |
| 2025-03-31 | 11 | $266.1M | 100 | |
| 2024-12-31 | 11 | $736.7M | 0 | |
| 2024-09-30 | 12 | $906.8M | 0 | |
| 2024-06-30 | 11 | $795.8M | 0 | |
| 2024-03-31 | 13 | $780.0M | 0 | |
| 2023-12-31 | 13 | $888.5M | 0 | |
| 2023-09-30 | 13 | $458.4M | 0 | |
| 2023-06-30 | 12 | $389.1M | 0 | |
| 2023-03-31 | 10 | $114.0M | 0 | |
| 2022-12-31 | 11 | $106.9M | 0 | |
| 2022-09-30 | 10 | $107.7M | 0 | |
| 2022-06-30 | 10 | $117.6M | 0 | |
| 2022-03-31 | 11 | $172.1M | 0 | |
| 2021-12-31 | 11 | $175.9M | 0 | |
| 2021-09-30 | 10 | $205.7M | 0 | |
| 2021-06-30 | 14 | $308.1M | 0 | |
| 2021-03-31 | 13 | $298.9M | 52 | |
| 2020-12-31 | 10 | $472.4M | 0 |
Euclidean Capital LLC's most significant position changes for 2026-03-31: Sold out: Ss Spdr S&p 500 ETF Trust-us (SPY); Sold out: Rapt Therapeutics INC (RAPT); Add: Vanguard Ftse All-world Ex-u (VEU) — shares +8.47%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | VEU | Vanguard Ftse All-world Ex-u | +2.6% | +8.47% | Add |
| 2 | ORIC | Oric Pharmaceuticals INC | +1% | — | Unchanged |
| 3 | ALEC | Alector INC | +0.2% | — | Unchanged |
| 4 | SRZN | Surrozen INC | +0.1% | — | Unchanged |
| 5 | SRZNW | Surrozen Inc-cw25 | — | — | Unchanged |
| 6 | TNYA | Tenaya Therapeutics INC | 0% | — | Unchanged |
| 7 | PMVP | Pmv Pharmaceuticals INC | -0.1% | — | Unchanged |
| 8 | FHTX | Foghorn Therapeutics INC | -0.4% | — | Unchanged |
| 9 | VTV | Vanguard Value ETF | -0.9% | — | Unchanged |
| 10 | INDA | Ishares Msci India ETF | -1% | — | Unchanged |
| 11 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | EXIT | Sold out |
| 12 | RAPT | Rapt Therapeutics INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-15 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-17 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-14 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-14 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-15 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-15 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-14 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-12-01 | Amendment | View on EDGAR |
| 2023-09-30 | 2023-11-14 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-14 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-15 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-14 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-15 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-15 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-11-15 | Amendment | View on EDGAR |
| 2021-06-30 | 2021-08-16 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-17 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-12 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001506073
Total reported value
$392.4M
321 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001672355
Total reported value
$392.4M
24 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001645721
Total reported value
$392.4M
26 stks
2026-03-31
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0000059558
Total reported value
$3.5B
19 stks
2026-03-31
2 of the top 5 holdings overlap, including Vanguard Value ETF
CIK 0001512581
Total reported value
$5.4B
1,447 stks
2020-09-30
Stale — no recent filing
2 of the top 5 holdings overlap, including Vanguard Ftse All-world Ex-u
CIK 0001535477
Total reported value
$786.3M
81 stks
2019-03-31
Stale — no recent filing
2 of the top 5 holdings overlap, including Vanguard Ftse All-world Ex-u